Reinventing Blood Testing for Better Patient Experience with Web Golinkin, President at Babson Diagnostics

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. About Web Golinkin: Web Golinkin has focused his career on making health information and care more accessible and affordable. He has done this as CEO of five companies over the past 35 years, including three he co-founded. These companies include the largest cable TV network devoted to health (America’s Health Network), one of the nation’s largest operators of retail-based clinics (RediClinic), a leading population health management company (Health Dialog), and one of the nation’s largest operators of urgent care clinics (FastMed). Web also co- founded the Convenient Care Association and served as its Chair for many years. He has been widely covered in the national media and has spoken at numerous healthcare conferences. Things You’ll Learn: Blood testing drives around 70% of medical decisions but has not fundamentally changed in decades. About one-third of patients skip testing due to discomfort or inconvenience. BetterWay uses a fingerstick method and requires 90% less blood. The system eliminates the need for a phlebotomist, enabling more flexible staffing. Automated sample preparation reduces errors and manual workload. The approach is backed by extensive validation, including IRB studies and peer-reviewed data. With an NPS of 79, compared to negative industry scores, it delivers a significantly better patient experience while supporting ambulatory growth, reducing leakage, and improving chronic disease management. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email. Follow Babson Diagnostics on LinkedIn and explore their website. Learn more about BetterWay here.